Skip to main content
Log in

Serological diagnosis and follow-up of severe neurocysticercosis using HP10 antigen detection

  • Practice Point
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Correa D et al. (1989) Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg 83: 814–816

    Article  CAS  Google Scholar 

  2. Nguekam et al. (2003) Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite 10: 65–68

    Article  CAS  Google Scholar 

  3. Zamora H et al. (2005) Drop in antigen levels following successful treatment of subarachnoid neurocysticercosis. Am J Trop Med Hyg 73: S41

    Article  Google Scholar 

  4. Garcia HH et al. (2000) Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 94: 673–676

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, H. Serological diagnosis and follow-up of severe neurocysticercosis using HP10 antigen detection. Nat Rev Neurol 3, 488–489 (2007). https://doi.org/10.1038/ncpneuro0563

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0563

  • Springer Nature Limited

Navigation